Clinical Study

A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Assignment Study To Assess The Efficacy And Safety Of Reparixin In Pancreatic Islet Auto-Transplantation.

Posted Date: Aug 12, 2017

  • Investigator: Syed Ahmad
  • Co-Investigator: Kimberly Jacob Anderson
  • Specialties:
  • Type of Study: Drug

The main purpose of this study is to evaluate the safety and effectiveness of the study drug in patients who have undergone pancreatic islet auto-transplantation.

Criteria:

To Be Eligible Patients Must Have Been Diagnosed With Chronic Pancreatitis And Are Scheduled To Have Pancreas Removed And Have A Pancreatic Islet Auto-Transplant

Keywords:

Pancreatic Islet Auto-Transplantation, Chronic, Rep0112, Pancreatitis, Null

For More Information:

Uc Cancer Institute
513-584-7698
kastla@uc.edu

  • Search Clinical Studies

  • Research in the News

    UC Study Finds Organs from HCV Donors May Be Safe for Liver Transplant

    A UC researcher says livers from HCV patients who test positive for theantibody made to fight the disease may pose a modest risk of infection and beacceptable for transplant